Four Mega-Franchises and a Woke Lecture Die at the Box

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
92
Four Mega-Franchises and a Woke Lecture Die at the Box Office
[url=Four Mega-Franchises and a Woke Lecture Die at the Box Office]< >[/url]

This weekend’s box office wiped out two franchises, cemented the failure of two others, and mercy-killed one of those woke entries only pompous critics adore.

We’ll start with Men in Black: International, which is doing even worse than those already-dire predictions of $30 million. Deadline reports this stinker will open to a pathetic $25 million, which is less than half of what all three of its predecessors opened to. Even the 22-year-old original launched with $51 million in 22-year-old dollars.

As I mentioned in my review, MIB4 has no swagger, no sex appeal, and no laughs; just a confusing story, bad special effects, and a bland leading man who is treated like an imbecile because he’s white and hetero and we must now grovel before the woke.

This is the second franchise Hemsworth has helped destroy by allowing himself to be publicly emasculated. The first was that dreadful Ghostbusters remake.

Samuel L. Jackson’s Shaft had been projected to land in the $15 to $20 million range. In the real world it crash landed at $8 million.

Eight million for a name brand with a name star opening in nearly 2400 theaters.

How is that even possible?

Well, for whatever lunatic reason, Warner Bros. decided to turn a 48-year-old franchise built on grit and testosterone into a lame family sitcom.

The original Shaft, the 1971 masterpiece that currently sits at number 59 on my list of the greatest American movies of all time, personified cool, sex, masculinity, and what it means to be one man against the system. And while I’m as much of a purist as any rabid movie fan, that doesn’t mean I’m unreasonable. For example, John Singleton’s 2000 sequel/remake, which is also called Shaft, is pretty freakin’ great.

But when I saw the trailer for this-third-movie-called-Shaft — you gotta be kidding me. This is like turning the James Bond franchise into a musical, or Tootsie 2 into a psychological thriller, or Caddyshack 3 into a monster movie

What in the world was Warner Bros. thinking?

A franchise about a “bad mother-shut-your-mouth” is now The Aging Bickersons.

John Shaft, the John Shaft (The Mighty Richard Roundtree), the original bad mother-shut-your-mouth is now Bad Grandpa?

There’s a fan base for this brand. Back in 2000, Shaft opened to $22 million and I would have happily stood in line to watch Roundtree take his iconic character into 2019, but that trailer was flat-out depressing.

Shame on everyone.

Another bomb is Mindy Kaling’s Late Night, which was sold as woke-female-of-color-lecture, because we all go to the movies to get talked down to. Oh, wait — actually we don’t, which is why, like a third-wave feminist on her honeymoon, this wide release is just lying there and not doing anything with a pathetic $4.5 million opening.

Rocketman is officially toast. In its third weekend, the Elton John biopic has grossed just $65 million. What was supposed to be this year’s Bohemian Rhapsody will make about a third of that blockbuster.

Bohemian Rhapsody was a PG-13 movie about an extraordinary talent who happened to be a homosexual.

Rocketman is an R-rated movie with a gay sex scene about a homosexual addicted to drugs and sex who sings songs.

No thank you.

Freddie Mercury was not defined by what he did with his penis, he was defined by his artistry and second-to-none showmanship. This is what people want to see, not some sleazy soap opera we’ve already seen a million times.

Also toast is the Godzilla franchise with Godzilla: King of the Monsters earning a pathetic $7 million in its third weekend. This sucker is barely going to break $100 million domestic and $300 million worldwide, which means it’s going to lose close to $100 million.

I just hope the filmmakers enjoyed blaming mankind for everything.

And then there’s Dark Phoenix, whose feminist superpower is the ability to kill a beloved, 20-year-old franchise. With a second weekend collapse of 77 percent, X-Men 10 will sit at a measly $50 million after ten days — which means it will not even clear $100 million domestic and possibly gross less than $200 million worldwide. That adds up to another $100 million loss.

Things will look a whole lot better next weekend when Toy Story 4 opens, an apolitical family film with universal appeal.

Two weeks later, over the Fourth of July weekend, Spider-Man: Far From Home will also brighten things.

Woke killed the summer box office.

Yep, Trump broke Hollywood.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading